Topic category
Pharmaceutical news and drug research.
The UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 3 Medicines Recall, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 3 Medicines Recall, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning UPDATE, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 2 Medicines Recall, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 2 Medicines Recall, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.
Read articleThe UK regulator has issued a safety notice concerning Class 4 Medicines Defect Notification, with guidance for affected healthcare services.
Read articleA sealed 2.5 mg carton from batch GR155023 contained two 10 mg blister packs, creating a risk of unintentional overdose, the UK regulator says.
Read articleThe recall covers specified 1 mL and 1.5 mL applicators after a packaging-process issue that could allow pathogen contamination and raise infection risk.
Read articleBatch 4L01372H is being recalled over possible small metal particles found during shelf-life testing; the MHRA says no harm reports had been received.
Read article
Ana Salazar Modela Tu Cuerpo is recalling lot 25M12F of its weight-loss supplement after FDA testing found undeclared fluoxetine in the daytime tablets and toxic DNP in the nighttime tablets.
Read article